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Presence of the Y chromosome in human female and 
its absence in the male is an abnormal condition, imp-
lying a spectrum of genetic abnormalities. In this 
communication, we describe studies conducted on a 
17-year-old patient (HK-459) with stigmata of Turner 
syndrome. We analysed the hormonal profile of the 
subject, chromosomal constitution and DNA for the 
five different loci encompassing both the arms of the 
Y chromosome. Chromosomal analysis showed mosa-
icism containing 45,X/46,X,+mar but no Y chromo-
some. The X chromosome and all the autosomes of the 
patient and her parents were normal. The Southern 
analysis of the patient’s genomic DNA with probes 
specific to DYZ1 locus did not detect the correspond-
ing Y-specific signal. Similarly, primers RG4, RG7 
and PABY, corresponding to SRY gene and pseudo-
autosomal boundary regions respectively, fai ed to 
generate Y-specific amplicons. However, primers 
DYZ3 and DYS1, representing centromeric hetero-
chromatic and euchromatic regions respectively, on 
the long arm of the Y chromosome uncovered Y-spe-
cific signals in the patient and her mother. Sequence 
analysis of DYS1-specific (710 bp) amplicon from the 
patient, both of her parents and two normal males 
showed insertion/deletion mutation in the patient. It is 
inferred that the Y-derived marker chromosome in 
the patient is of maternal origin and had undergo e 
post-zygotic mutational events. The possible prognos-
tic implications of this combined approach in the  
patient(s) with stigmata of Turner syndrome are dis-
cussed here. 
 
A normal human female is homogametic with two X-
chromosomes and the male is hterogametic with XY 
chromosomes. An imbalance in the sex chromosome con-
stitution causes several genetic anomalies, including 
Turner syndrome. Turner’s patients often have mosaic 
karyotype with second cell lines carrying numerical or 
structural aberrations f the sex chromosome1. A sizable 
body of literature is available on the aberrant Y chromo-
some or its complete absence in the Turner patients2–6. In 
several studies, post-zygotic mutational events and loss 
of the Y chromosome heterochromatin (Yqh) have been 
reported7,8. It has been suggested that Yqh plays a role in 
immune response during early embryonic development 
and control of normal male development9. Further, its 
deletion has been associated with spontaneous abortion10 
and Noonan’s syndrome11,12. The human Y chromosome 
is known to carry relatively few functional genes and 
thus far, only 33 genes have been reported13. Also, more 
than 95% of the Y chromosome does not undergo recom-
bination during meiosis and maintains its structural integ-
rity. Majority of repeat elements associated with Yq 
region are distributed evenly along its entire length14,15. 
Thus, the quest for functional prioritization of Y-li ked 
loci and phenotypic effects of their loss or gain in patie-
nts with stigmata of Turner syndrome, with or without 
marker chromosome is of relevance. In this study, we 
present results of our analysis on one such marker chro-
mosome in a phenotypic female patient (HK-459) with 
s igmata of Turner syndrome, analysing five different 
loci (PABY, SRY, DYZ3, DYS1 and DYZ1) encom-
passing both the arms of the Y chromosome6.  
 In view of the imperfect Turner features and seemingly 
normal parentage, we studied chromosomal and hormo-
nal profiles of the patient. For ascertaining the presence 
of DYZ1 locus, Southern blot hybridization was con-
ducted on DNA samples of the patient (HK-459), her 
parents and normal individuals of both sexes using syn-
thetic oligonucleotide (OAT20Y)16 and cloned (pSA1F) 
probes6. Remaining four loci, PABY, SRY17,18, DYZ3 
(refs 19, 20) and DYS1 (ref. 21) were analysed using 
PCR approach. Blood samples from all the individuals 
listed above were obtained with their informed consent. 
Ethical guidelines of the Guru Nanak Dev University, 
Amritsar were strictly followed during sample collection. 
 Chromosome preparation and G-banding were carried 
out following established protocols16. Karyotyping was 
done using Zeiss microscope fitted with automatic karyo-
typing system (Karyotec 2000, Amgenics, Israel). 
 DNA from the blood was isolated following standard 
protocols22. Approximately 0.5 mg of genomic DNA from 
each of the above-m ntioned subjects was used for dige-
stion with HaeIII, and RsaI enzymes in 20 ml independ-
ent reactions following supplier’s specifications (New 
England Biolabs, USA). Digested DNA was electropho-
resed on a 20 cm long, 1.5% agarose gel in 0.5 X TBE 
buffer (pH 8.2). The DNA was transferred onto the nylon 
membrane23 and UV-fixed using Stratalinker (Stratagene, 
USA). Blot hybridization with cloned and synthetic oligo 
probes representing DYZ1 locus and autoradiography 
were conducted following standard protocols16,24. 
 F r assessing hormonal profiles, standard protocols 
were followed16.  
 A set of oligo primers for the loci mentioned earlier 
was used for amplification of genomic DNA from two 
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Table 1. Y chromosome-r lated primers representing different loci used for PCR amplification 
  Annealing Amplicon 
Loci Set of primers temperature (oC) size (bp) Reference 
 
SRY (i) 5¢GGTCAAGCGACCCATGAAYGCNTT 3¢ 55 231 29 
  (ii) 5¢GGTCGATACTTATAGTTCGGGTAYTT 3¢ 
PABY (i) 5¢GTACTACCTTTAGAAAACTAGTATTTTCCC3¢ 54 970 19 
  (ii) 5¢GAATTCTTAACAGGACCCATTTAGGATTAA3¢ 
DYZ3 (i) 5¢ATGATAGAAACGGAAATATG3¢ 54 120 19 
  (ii) 5¢AGTAGAATGCAAAGGGCTCC3¢ 
DYS1 (i) 5¢ AATAGAGCCTTATCAGCAGA3¢ 54 710 19 
  (ii) 5¢ AGTCAGTCTGGATGTTTCAG3¢ 
(i) and (ii) represent forward (5¢) and reverse (3¢) primer sequences respectively. 
Reproducibility of the result was confirmed by conducting PCR amplification at least thrice.  
 
 
 
 
 
Figure 1. G-banded partial metaphases from the patient showing XO 
(a) and X,+mar chromosomes (b).  
 
 
normal males and females, the patient (HK-459) and both 
her parents, following standard protocols25. Details about 
these primers, their annealing temperatures, size of the 
expected amplicons and their corresponding references 
are given in Table 1.  
 The 710 bp band(s) amplified using DYS1-specific-
primers and DNA samples from two normal males, the 
patient and both her parents were resolved on the agarose 
gel and processed independently for purification and 
cloned in pGEM-T easy vector (Stratagene Inc., USA) 
following manufacturer’s instructions. From the resultant 
clones, one each of all the samples – patient’s mother 
(pAS1), patient (pAS2), patient’s father (pAS3) and two 
normal males (pAS4) and (pAS5) respectively, was fully 
sequenced using Sequenase kit (Amersham, version 2.0) 
following standard method26. The sequences were depos-
ited in GenBank with the following accession numbers: 
pAS1-AJ344999; pAS2-AJ345000; pAS3-AJ344998; 
pAS4-AJ344996; pAS5-AJ344997. 
 Multiple alignment of 710 bp sequences from all the 
clones (pAS1–5) was conducted on ebi server (http:// 
www2.ebi.ac.uk) using Clustal W program and default 
parameters to uncover possible gross sequence modulation. 
 The patient suffering from primary amenorrhea was 
born following full-term, uneventful pregnancy and nor-
mal vaginal delivery. Although face appearance and car-
rying angle were normal, the body build was short, but 
proportionate. No webbing of the neck was detected. 
During the onset of puberty, breast development and 
menstruation was induced following hormonal treatment. 
Ultrasound analysis showed normal kidneys with respect 
to size, shape, outline and echo texture. The external 
genitalia were normal, but pubic hair showed sparse 
growth. The uterus was small and infantile and ovaries 
were not detected.  
 Hormonal profile showed an abnormal level of E2 
(0.01 pg/mg), which was less than that observed in chil-
dren (0.12–0.04 pg/mg). The FSH was found to be 
52.33 mIU/ml, which is equivalent to the levels (28–
130 mIU/ml) of a post-menopausal female. LH showed a 
value of 23.37 mIU/ml, which corresponds to that of a 
female (25–64 mIU/ml) during the ovulation phase of her 
cycle.  
 A total of 90 G-banded metaphases was analysed. Both 
the parents were normal with respect to their chromo-
some constitutions, but the patient (HK-459) showed 
mosaicism, 45,X/46,X,+mar chromosomes. Nearly 50% 
of the metaphases showed 45,X chromosome constitution 
(Fi ure 1 a) and the remaining had a small chromosome 
(46,X,+mar) without its homologue. This was referred to 
as the marker chromosome (Figure 1 b). 
 As mentioned earlier, DYZ1 locus was analysed using 
synthetic oligo and cloned probes that revealed a 3.4 kb 
band with HaeIII-digested DNA samples in normal 
males16,27. The remaining Y chromosome-linked loci 
(PABY, SRY, DYZ3 and DYS1), shown tentatively in 
the schematic presentation (Figure 2) were assessed for 
their presence by employing PCR approach.  
 Southern hybridization showed that the patient and her 
mother were both negative for heterochromatic region 
DYZ1 with oligo probe OAT20Y27 and genome-d rived 
cloned probe pSA1F6. The male-specific 3.4 kb band was 
observed only in normal male and the patient’s father 
with OAT20Y probe (Figure 3 a). The cloned probe 
pSA1F with HaeIII enzyme also showed male-specific 
bands in the patient’s father and normal males but not in 
the patient DNA or that of her mother (not shown). 
Similarly, typing of DNA samples with RsaI enzyme and 
pSA1F clone showed several discernible bands specific 
to normal males and the patient’s father, which were abs-
ent i  the patient, her mother and normal females (Figure 
3 b arrow heads). Thus, DYZ1 locus in the patient was 
not detected. 
a b 
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 Following PCR amplification with SRY-related prim-
ers RG4 and RG7, a 231 bp band of expected size was 
observed in normal males and the patient’s father, 
whereas the same was absent in normal females, the pat-
ient and her mother (Figure 4 a). Similarly, primers spe-
cific to PABY region produced a 970 bp band in normal 
males and the patient’s father but not in the patient, her 
mother and normal female DNA sample  (Figure 4 b). 
Thus, both the patient and her mother were negative for 
SRY and PABY loci. On the other hand, primers corre-
sponding to DYZ3 and DYS1 loci of the Y chromosome 
uncovered 120 bp and 710 bp bands respectively, in the 
patient, both her parents a d normal males (Figure 4 c, d) 
that are absent in normal females. Thus, both the patient 
and her mother were positive for DYZ3 and DYS1 loci of 
the Y chromosome.  
 Sequencing of the recombinant clones specific to 
DYS1 locus representing pAS1 (patient’s mother), pAS2 
(the patient), pAS3 (patient’s father), pAS4 and pAS5 
(two normal males) was conducted. A comparison of the 
autoradiogram showed marked deletion/addition (muta-
tion) in the range of nt 172–225 in the patient but not in 
other samples, in addition to several point mutations 
(Figure 5). Multiple sequence alignment of these clones 
using Clustal W (http://www2.ebi.ac.uk) program showed 
insertion of the 33 nucleotides (5¢CAG TCG AAG TTA 
TTT CTT ATG CCC ACC AGT CAG 3¢) within the 
region 588–625 nt and deletion of 44 nucleotid s (5¢CCT 
GGT GAA TGT GGA TAA GCA GAG TAA GCC TGA  
AAA TAA AGT TT 3¢) within the region 361–440 nt in 
the patient (Figure 6). A detailed search on the origin of 
these sequences was conducted using default server http: 
//www.ncbi.nlm.nih.gov./BLAST. No homology of the  
  
 
 
Figure 2. Y chromosome map (partial) showing tentative positions of 
the five loci analysed in the present study (see text for details). 
inserted sequences was found with any of the entries in 
GenBank and thus the origin of these sequences remained 
unclear.  
The homozygous (XX) or heterozygous (XY) sex 
chromosome constitution is essential for survival of the 
conceptuses during early embryogenesis and subsequent 
normal development28. Patients with 45,X/46,X,+mar or 
other mosaic conditions survive owing to the presence of 
critical sequences on the homologous loci. However, due 
t  haploinsufficiency, their ensuing post-natal normal 
 
 
 
 
 
 
 
Figure 3. Typing of genomic DNA from normal individuals, patient 
and her parents with HaeIII enzyme and oligo probe OAT20Y (a) and 
RsaI enzyme and cloned probe pSA1F (b). Lane 1 has molecular size 
marker in kb. Note the absence of Y-specific band(s) in the patient, her 
mother and normal females and the presence of the same in the father 
and normal males.  
a 
b 
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Figure 4. PCR amplification of genomic DNA from normal individu-
als, patient and her parents with different sets of defined primers re-
lated to: a, SRY; b, PABY; c, DYZ3 and , DYS1 loci. Male-specific 
signals corresponding to DYZ3 and DYS1 loci in the patient and her 
mother are shown in panels c andd respectively.  
 
 
 
 a b c d 
 
Figure 5. Comparative autoradiograms of the DYS1 locus (partial 
sequence) showing mutational region in the patient (HK-459) com-
pared to other samples (see text for details). 
 
 
development and eventual fertility status are seriously 
affected. The Y-derived marker chromosome inherited 
from the mother seems to contribute towards genetic im-
balance, though this alone may not be responsible for 
haploinsufficiency. This is due to the fact that only about 
50% of the cells in the proband had X chromosome. The 
present study seems to be a rare one since no such gross 
deletion/insertion in the DYS1 region has been reported 
earlier. The indels reported herein may serve as a refer-
ence point for comparison of the possible sequence 
modulation within this region in subsequent studies on 
more number of samples.  
 The marker chromosome analysed in the patient was 
positive for DYZ3 and DYS1 loci, which were also obse-
rved in her mother. How then was the mother normal is 
not clear at this stage. From the data, it is inferred that 
owing to non-disjunction of the X chromosome during 
oogenesis in mother, the patient inherited normal X from 
her father and the marker chromosome from her m ther. 
Further, during post-zygotic sequence modulation, 
marked deletion/insertion within the DYS1 region took 
place in the patient. In addition, perhaps several other 
important loci were also affected resulting in Turner syn-
drome in the proband. Although ultrasonography did not 
detect ovaries or any kind of streak gonads, partial gona-
dal dysgenesis in the patient may not be ruled out be-
cause in the absence of SRY gene, streak gonads are obse-
rved. Although it is difficult to ascertain the parental ori-
gin of the marker chromosome unequivocally, it is more 
likely that the same originated from the mother since she 
was positive for DYS1 and DYZ3 loci. If the maternal 
origin of the marker chromosome is assumed, it involved 
only insertion/deletion of the sequences in the DYS1 
locus. However, if the marker chromosome is construed 
to be of paternal origin, this would have involved a great 
deal of post-zygotic mutational events leading to a siz-
able part of the deletion of the father’s Y chromosome 
followed by insertion/deletion of the sequences. This 
seems less likely, also because during chromosome 
analysis, remarkably, none of the cells in the patient had 
the father’s (normal) Y chromosome. Thus, marker 
chromosome seems to be of maternal origin.  
 In Turner cases, due to mosaicism or gross aberration 
of the Y chromosome, the latter may be under-r pre-
sented and escape detection during routine karyotyping. 
A combined molecular and cytogenetic approach to trace 
the origin of such chromosomes is of diagnostic rele-
vance. In the present study, marker chromosome repre-
senting an aberrant Y has retained the centromeric 
(DYZ3) and euchromatic (DYS1) sequences. In the abse-
nce of SRY and other regulatory sequences, one may infer 
that the development of male gonads will be suppressed. 
This, in turn, would also exclude the possibility of its 
neoplastic development. However, with the Yp deletion 
resulting in the loss of SRY gene, gonadoblastoma may
still occur because genes responsible are putatively 
located in the pericentromeric regions of the Y chromo-
some4. In this context, analysis of more number of Y-
d r ved marker chromosome(s) would enable to ascertain 
preferential involvement of any of the above-mentioned 
loci in the Turner cases. The present study complements 
routin diagnosis of the aberrant Y or its derived marker 
 
a 
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Figure 6. Multiple alignment of recombinant clones representing subset sequences of DYS1 locus from two normal 
males, patient and both her parents using Clustal W software. Clones pas denote: 1, Mother; 2, Patient; 3, Father; 4 and 5, 
Normal males. Deletion/addition of sequences in patient is shown compared to other samples (see text for details). 
 
 
 
chromosome, facilitating genetic counselling and clinical 
management of the patient with stigmata of Turner syn-
drome. 
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